342 related articles for article (PubMed ID: 19690561)
1. Neonatal screening for congenital adrenal hyperplasia.
White PC
Nat Rev Endocrinol; 2009 Sep; 5(9):490-8. PubMed ID: 19690561
[TBL] [Abstract][Full Text] [Related]
2. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
3. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
[TBL] [Abstract][Full Text] [Related]
4. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
7. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
9. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia.
Vats P; Dabas A; Jain V; Seth A; Yadav S; Kabra M; Gupta N; Singh P; Sharma R; Kumar R; Polipalli SK; Batra P; Thelma BK; Kapoor S
Indian Pediatr; 2020 Jan; 57(1):49-55. PubMed ID: 31937698
[TBL] [Abstract][Full Text] [Related]
11. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
12. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
14. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
16. Determination of a steroid profile in heel prick blood using LC-MS/MS.
Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
[TBL] [Abstract][Full Text] [Related]
17. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
[TBL] [Abstract][Full Text] [Related]
19. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]